Search

everythinglearnresearchcommunity

for

Search:↓

Women with AGA often face anxiety, depression, and low self-esteem; psychological support is important.

Children's hair grows in different types from before birth through puberty, with growth rates and characteristics varying by age, sex, and race.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

The rise in tinea capitis cases in Stockholm is linked to increased African immigration.

A mother's western diet can make her milk toxic, causing inflammation and hair loss in babies.

Androgens significantly affect female hair loss, and hormonal treatments may help.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

New drug delivery methods can make natural compounds more effective and stable.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Female hair loss linked to metabolic syndrome, not in males.

The document concludes that there is no clear definition of adequate health insurance, and a consistent method to measure underinsurance is needed.

Social housing is a system for those with limited financial resources, needing subsidies and an allocation system, with Germany fitting this criteria.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Skin problems can be linked to sexual abuse, requiring careful medical and psychological evaluation.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Minoxidil use during pregnancy may cause fetal harm.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

New drugs for heart disease may be developed from molecules secreted by stem cells.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

α-type filaments in guinea pig hair follicles have unique structural features.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

Recognizing and managing skin-related psychiatric disorders in children is crucial for effective treatment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.